KRYS
$65.89
Krystal Biotech
$.59
.90%
KRYS
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.74)
Revenue:  $0.00 Mil
Monday
Aug 9
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when KRYS reports earnings?
Beat
Meet
Miss

Where is KRYS's stock price going from here?
Up
Flat
Down
Stock chart of KRYS
Analysts
Summary of analysts' recommendations for KRYS
Score
Grade
Pivots
Resistance
$69.26
$67.95
$66.92

$65.61

Support
$64.58
$63.27
$62.24
Tweet
Growth
Description
Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.